These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 19463399)

  • 1. Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention.
    Mehta RH; Ou FS; Peterson ED; Shaw RE; Hillegass WB; Rumsfeld JS; Roe MT;
    JACC Cardiovasc Interv; 2009 Jan; 2(1):56-64. PubMed ID: 19463399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators.
    Hussain F; Philipp RK; Ducas RA; Elliott J; Džavík V; Jassal DS; Tam JW; Roberts D; Garber PJ; Ducas J
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):540-8. PubMed ID: 21547996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Welsh RC; Granger CB; Westerhout CM; Blankenship JC; Holmes DR; O'Neill WW; Hamm CW; Van de Werf F; Armstrong PW;
    JACC Cardiovasc Interv; 2010 Mar; 3(3):343-51. PubMed ID: 20298996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).
    Zeymer U; Vogt A; Zahn R; Weber MA; Tebbe U; Gottwik M; Bonzel T; Senges J; Neuhaus KL;
    Eur Heart J; 2004 Feb; 25(4):322-8. PubMed ID: 14984921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Coronary Thrombectomy in Cardiogenic Shock Complicating ST-Segment Elevation Myocardial Infarction.
    Suzuki M; Sumiyoshi T; Miyachi H; Yamashita J; Yamasaki M; Miyauchi K; Yamamoto T; Nagao K; Tomoike H; Takayama M
    Am J Cardiol; 2015 Jun; 115(12):1649-54. PubMed ID: 25888301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock.
    Lim HS; Farouque O; Andrianopoulos N; Yan BP; Lim CC; Brennan AL; Reid CM; Freeman M; Charter K; Black A; New G; Ajani AE; Duffy SJ; Clark DJ;
    JACC Cardiovasc Interv; 2009 Feb; 2(2):146-52. PubMed ID: 19463417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Alhadramy O; Westerhout CM; Brener SJ; Granger CB; Armstrong PW;
    Am Heart J; 2010 May; 159(5):899-904. PubMed ID: 20435202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience.
    Pedrazzini GB; Radovanovic D; Vassalli G; Sürder D; Moccetti T; Eberli F; Urban P; Windecker S; Rickli H; Erne P;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):627-33. PubMed ID: 21700248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes.
    Ndrepepa G; Mehilli J; Schulz S; Iijima R; Keta D; Byrne RA; Pache J; Seyfarth M; Schömig A; Kastrati A
    J Am Coll Cardiol; 2008 Aug; 52(7):512-7. PubMed ID: 18687242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year clinical outcome of elderly patients undergoing angioplasty for ST-elevation myocardial infarction complicated by cardiogenic shock: the importance of 3-vessel disease and final TIMI-3 flow grade.
    De Felice F; Guerra E; Fiorilli R; Parma A; Musto C; Nazzaro MS; Violini R
    J Invasive Cardiol; 2014 Mar; 26(3):114-8. PubMed ID: 24610504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry).
    Cavender MA; Milford-Beland S; Roe MT; Peterson ED; Weintraub WS; Rao SV
    Am J Cardiol; 2009 Aug; 104(4):507-13. PubMed ID: 19660603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between neutrophil/lymphocyte ratio and infarct-related artery patency before mechanical reperfusion in patients with ST-elevation myocardial infarction.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Ocek AH
    Coron Artery Dis; 2014 Mar; 25(2):159-66. PubMed ID: 24326783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.
    Klein LW; Shaw RE; Krone RJ; Brindis RG; Anderson HV; Block PC; McKay CR; Hewitt K; Weintraub WS;
    Am J Cardiol; 2005 Jul; 96(1):35-41. PubMed ID: 15979429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.
    Zeymer U; Tebbe U; Weber M; Vohringer HF; Jaksch R; Bischoff KO; Toepel W; Marsalek P; Horn S; Neuhaus KL;
    J Invasive Cardiol; 2003 Jul; 15(7):385-9. PubMed ID: 12840235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularization.
    Mylotte D; Morice MC; Eltchaninoff H; Garot J; Louvard Y; Lefèvre T; Garot P
    JACC Cardiovasc Interv; 2013 Feb; 6(2):115-25. PubMed ID: 23352816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
    Rakowski T; Siudak Z; Dziewierz A; Birkemeyer R; Janzon M; Mielecki W; Zmudka K; Dubiel JS; Dudek D
    Kardiol Pol; 2012; 70(3):215-21. PubMed ID: 22430397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of rescue angioplasty for ST-elevation myocardial infarction with high utilization rates of glycoprotein IIb/IIIa inhibitors.
    Shugman IM; Hsieh V; Cheng S; Parikh D; Tobing D; Wouters N; van der Vijver R; Lo Q; Rajaratnam R; Hopkins AP; Lo S; Leung D; Juergens CP; French JK
    Am Heart J; 2012 Apr; 163(4):649-56.e1. PubMed ID: 22520531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.